PH24727A - Agents having renal function improving effect - Google Patents

Agents having renal function improving effect

Info

Publication number
PH24727A
PH24727A PH36474A PH36474A PH24727A PH 24727 A PH24727 A PH 24727A PH 36474 A PH36474 A PH 36474A PH 36474 A PH36474 A PH 36474A PH 24727 A PH24727 A PH 24727A
Authority
PH
Philippines
Prior art keywords
renal function
improving effect
agents
function improving
effect
Prior art date
Application number
PH36474A
Other languages
English (en)
Inventor
Isao Yamaguchi
Taku Nagao
Yosiaki Akimoto
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of PH24727A publication Critical patent/PH24727A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH36474A 1987-02-10 1988-02-09 Agents having renal function improving effect PH24727A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2939687 1987-02-10

Publications (1)

Publication Number Publication Date
PH24727A true PH24727A (en) 1990-10-01

Family

ID=12274977

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36474A PH24727A (en) 1987-02-10 1988-02-09 Agents having renal function improving effect

Country Status (10)

Country Link
US (1) US4822789A (de)
EP (1) EP0278449B1 (de)
KR (1) KR930010583B1 (de)
AT (1) ATE81007T1 (de)
AU (1) AU603421B2 (de)
CA (1) CA1300024C (de)
DE (1) DE3874900T2 (de)
DK (1) DK67288A (de)
IL (1) IL85257A (de)
PH (1) PH24727A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85257A (en) * 1987-02-10 1993-02-21 Tanabe Seiyaku Co Pharmaceutical compositions containing 2-(4-methoxyphenyl) 3-acetoxy-5-- (2-(dimethylamino) ethyl) -8-chloro-2,3- dihydro-1,5-benzothiazepin -4 (5h)-one having renal function-improving effect and diuretic effect
CA2061353A1 (en) * 1991-02-26 1992-08-27 Sakae Murata Prophylactic and curing agent for sequelae of cerebral neurocyte dyscrasia
AU3195295A (en) * 1994-07-15 1996-02-16 Loma Linda University Medical Center Natriuretic and anti-hypertensive compounds
EP1616184B2 (de) * 2003-03-27 2018-05-30 Children's Hospital Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
IL85257A (en) * 1987-02-10 1993-02-21 Tanabe Seiyaku Co Pharmaceutical compositions containing 2-(4-methoxyphenyl) 3-acetoxy-5-- (2-(dimethylamino) ethyl) -8-chloro-2,3- dihydro-1,5-benzothiazepin -4 (5h)-one having renal function-improving effect and diuretic effect

Also Published As

Publication number Publication date
DK67288A (da) 1988-08-11
US4822789A (en) 1989-04-18
AU603421B2 (en) 1990-11-15
KR930010583B1 (ko) 1993-10-30
IL85257A0 (en) 1988-07-31
EP0278449B1 (de) 1992-09-30
KR880009657A (ko) 1988-10-04
ATE81007T1 (de) 1992-10-15
EP0278449A2 (de) 1988-08-17
DE3874900T2 (de) 1993-04-01
CA1300024C (en) 1992-05-05
IL85257A (en) 1993-02-21
DE3874900D1 (de) 1992-11-05
EP0278449A3 (en) 1990-05-23
DK67288D0 (da) 1988-02-09
AU1146688A (en) 1988-08-11

Similar Documents

Publication Publication Date Title
AU7277987A (en) Pharmaceutically active tetrahydronaphthalene derivatives
GB8804164D0 (en) Bandage for administering physiologically active compound
EP0467218A3 (en) Combinations of active agents for skin care
PH24727A (en) Agents having renal function improving effect
AR242561A1 (es) Procedimiento para la preparacion de clorhidrato de s-(-)-1-propil-2',6'-pipecoloxilidida opticamente sustancialmente puro y procedimiento
AR245125A1 (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y sus sales de adicion de acidos farmaceuticamente aceptables.
EP0294053A3 (en) Physiologically active agent for agricultural use
HUT46508A (en) Insecticidal compositions comprising 6-member heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazine and process for producing the active ingredients
AU578794B2 (en) Concentrates of active ingredients for alkaline two- component cleaners, process for preparing same and use thereof
EP0495106A4 (en) Osteogenesis promoter
GB2190290B (en) Use of benzothiazepine derivatives in pharmaceutical compositions for improving constitution of lipids in blood.
HK45489A (en) Hypolipidemic composition
EP0437744A3 (en) Fungicidal combination of active agents
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
DE69001461D1 (en) Stereoisomere.
GB8921069D0 (en) Pharmaceutically active compound,preparation and use
IE873214L (en) Peptides
IE863157L (en) Preparation of n'-cyano-n-methyl-n"-¹(2-(5-methyl-1h-imidazol-4-yl) methyl) thio)ethyl) guanidine¹¹guanidine.
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
IT1237204B (it) Procedimento per la preparazione di 2-aril-3-idrossi-cis-2,3-diidro- 1,5-benzotiazepin-4(5h)-oni e derivati
WO1998042312A3 (en) Medicament having sclerosing activity
IT1255237B (it) Composizione farmaceuticaidrofila ad attivita' antiinfiammatoria
IT8520602V0 (it) Struttura di perno sagomato, utilizzabile per l'ancoraggio di protesi dentarie fisse.
ZA893677B (en) 2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid,8'-phenylmenthyl ester,especially for diltiazem
IT8620243A0 (it) Procedimento per la preparazione di n-[2-[[[5-(dimetilammino)metil]-2furanil] metil] tio] etil]-2-nitro1,1-etendiammine n'-sostituite quadra-2-nitro-1,1-etendiammine n'-sostituite.